Mr. Glenn has founded over twenty successful biotech companies, and has over twenty-five years of experience as Chairman/CEO and founder of Quidel, Prometheus Labs, DexCom, Santarus, Kanisa, Exagen Diagnostics, Alastin Skincare and Precision IBD. Mr. Glenn is also founder of SpineWave Zogenix, Cadence Pharmaceuticals, NovaCardia, Conception Technologies and Somaxon. Previously Mr. Glenn held various management positions, including Division General Manager with Allergan, Inc.